Biotech Stock A Big Winner After Pfizer Halts Weight-Loss Drug

Viking Therapeutics Inc (NASDAQ:VKTX) stock is up 10.1% to trade at $24.42 today, and traded as high as$27.09 earlier in the session. The drugmaker is on the move after Pfizer (PFE) halted the development of its weight-loss pill. Viking has two weight-loss drug candidates that have shown promising results in Phase 1 and 2 trials late last year. Sector peers Eli Lilly (LLY) and Novo Nordisk (NVO) -- two heavy hitters in the weight-loss treatment department -- are also higher today.VKTX is still down 39.3% i ...